Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013, Article ID 351895, 18 pages
http://dx.doi.org/10.1155/2013/351895
Research Article

Tanshinol Attenuates the Deleterious Effects of Oxidative Stress on Osteoblastic Differentiation via Wnt/FoxO3a Signaling

1The Key Laboratory of Molecular Biology, State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China
2Department of Pharmacology, Guangdong Key Laboratory for R&D of Natural Drug, Guangdong Medical College, Zhanjiang 524023, China
3Department of Orthopaedics and Traumatology, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong

Received 8 October 2013; Revised 3 December 2013; Accepted 4 December 2013

Academic Editor: Mohammad Abdollahi

Copyright © 2013 Yajun Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Abdollahi, B. Larijani, R. Rahimi, and P. Salari, “Role of oxidative stress in osteoporosis,” Therapy, vol. 2, no. 5, pp. 787–796, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. C. Manolagas, “From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis,” Endocrine Reviews, vol. 31, no. 3, pp. 266–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Almeida, “Unraveling the role of FoxOs in bone-Insights from mouse models,” Bone, vol. 49, no. 3, pp. 319–327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. L. Hui, C. W. Slemenda, and C. C. Johnston Jr., “Age and bone mass as predictors of fracture in a prospective study,” The Journal of Clinical Investigation, vol. 81, no. 6, pp. 1804–1809, 1988. View at Google Scholar · View at Scopus
  5. S. E. Painter, M. Kleerekoper, and P. M. Camacho, “Secondary osteoporosis: a review of the recent evidence,” Endocrine Practice, vol. 12, no. 4, pp. 436–445, 2006. View at Google Scholar · View at Scopus
  6. Y. Suzuki, “Secondary osteoporosis. A review of recent evidence focusing on glucocorticoid-induced osteoporosis and osteoporosis associated with rheumatoid arthritis,” Clinical calcium, vol. 17, no. 1, pp. 104–107, 2007. View at Google Scholar · View at Scopus
  7. P. Salari and M. Abdollahi, “A comprehensive review of the shared roles of inflammatory cytokines in osteoporosis and cardiovascular diseases as two common old people problem; actions toward development of new drugs,” International Journal of Pharmacology, vol. 7, no. 5, pp. 552–567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M.-T. Rached, A. Kode, L. Xu et al., “FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts,” Cell Metabolism, vol. 11, no. 2, pp. 147–160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. F. L. Muller, M. S. Lustgarten, Y. Jang, A. Richardson, and H. Van Remmen, “Trends in oxidative aging theories,” Free Radical Biology and Medicine, vol. 43, no. 4, pp. 477–503, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Almeida, L. Han, E. Ambrogini, R. S. Weinstein, and S. C. Manolagas, “Glucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblasts,” The Journal of Biological Chemistry, vol. 286, no. 52, pp. 44326–44335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Almeida, L. Han, M. Martin-Millan, C. A. O'Brien, and S. C. Manolagas, “Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting β-catenin from T cell factor- to forkhead box O-mediated transcription,” The Journal of Biological Chemistry, vol. 282, no. 37, pp. 27298–27305, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Wauquier, L. Leotoing, V. Coxam, J. Guicheux, and Y. Wittrant, “Oxidative stress in bone remodelling and disease,” Trends in Molecular Medicine, vol. 15, no. 10, pp. 468–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Kassem and P. J. Marie, “Senescence-associated intrinsic mechanisms of osteoblast dysfunctions,” Aging Cell, vol. 10, no. 2, pp. 191–197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. I. R. Garrett, B. F. Boyce, R. O. C. Oreffo, L. Bonewald, J. Poser, and G. R. Mundy, “Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo,” The Journal of Clinical Investigation, vol. 85, no. 3, pp. 632–639, 1990. View at Google Scholar · View at Scopus
  15. N. Suda, I. Morita, T. Kuroda, and S.-I. Murota, “Participation of oxidative stress in the process of osteoclast differentiation,” Biochimica et Biophysica Acta, vol. 1157, no. 3, pp. 318–323, 1993. View at Google Scholar · View at Scopus
  16. C. Galli, G. Passeri, and G. M. Macaluso, “FoxOs, Wnts and oxidative stress-induced bone loss: New players in the periodontitis arena?” Journal of Periodontal Research, vol. 46, no. 4, pp. 397–406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Ambrogini, M. Almeida, M. Martin-Millan et al., “FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice,” Cell Metabolism, vol. 11, no. 2, pp. 136–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. G. Essers, L. M. M. De Vries-Smits, N. Barker, P. E. Polderman, B. M. T. Burgering, and H. C. Korswagen, “Functional interaction between β-catenin and FOXO in oxidative stress signaling,” Science, vol. 308, no. 5725, pp. 1181–1184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Östman, K. Michaëlsson, J. Helmersson et al., “Oxidative stress and bone mineral density in elderly men: antioxidant activity of alpha-tocopherol,” Free Radical Biology and Medicine, vol. 47, no. 5, pp. 668–673, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Arslan, S. Orkun, G. Aydin et al., “Effects of ovariectomy and ascorbic acid supplement on oxidative stress parameters and bone mineral density in rats,” Libyan Journal of Medicine, vol. 6, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Liu, C.-F. Yang, B.-L. Lee, H.-M. Shen, S.-G. Ang, and C. N. Ong, “Effect of Salvia miltiorrhiza on aflatoxin B1-induced oxidative stress in cultured rat hepatocytes,” Free Radical Research, vol. 31, no. 6, pp. 559–568, 1999. View at Google Scholar · View at Scopus
  22. L. Wu, H. Qiao, Y. Li, and L. Li, “Protective roles of puerarin and Danshensu on acute ischemic myocardial injury in rats,” Phytomedicine, vol. 14, no. 10, pp. 652–658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-Y. Han, Y. Horie, J.-Y. Fan et al., “Potential of 3,4-dihydroxy-phenyl lactic acid for ameliorating ischemia-reperfusion-induced microvascular disturbance in rat mesentery,” American Journal of Physiology, vol. 296, no. 1, pp. G36–G44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. B.-L. Zhao, W. Jiang, Y. Zhao, J.-W. Hou, and W.-J. Xin, “Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury,” Biochemistry and Molecular Biology International, vol. 38, no. 6, pp. 1171–1182, 1996. View at Google Scholar · View at Scopus
  25. L. Cui, Y.-Y. Liu, T. Wu, C.-M. Ai, and H.-Q. Chen, “Osteogenic effects of D+β-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats,” Acta Pharmacologica Sinica, vol. 30, no. 3, pp. 321–332, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Cui, T. Li, Y. Liu et al., “Salvianolic acid b prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesis,” PLoS ONE, vol. 7, no. 4, Article ID e34647, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. P. S. Sharif, S. Nikfar, and M. Abdollahi, “Prevention of bone resorption by intake of phytoestrogens in postmenopausal women: a meta-analysis,” Age, vol. 33, no. 3, pp. 421–431, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Rayalam, M. A. Della-Fera, and C. A. Baile, “Synergism between resveratrol and other phytochemicals: implications for obesity and osteoporosis,” Molecular Nutrition and Food Research, vol. 55, no. 8, pp. 1177–1185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Mizutani, K. Ikeda, Y. Kawai, and Y. Yamori, “Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats,” Journal of Nutritional Science and Vitaminology, vol. 46, no. 2, pp. 78–83, 2000. View at Google Scholar · View at Scopus
  30. Z. Dai, Y. Li, L. D. Quarles et al., “Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation,” Phytomedicine, vol. 14, no. 12, pp. 806–814, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Li, C. Luna, I. D. Navarro et al., “Resveratrol prevention of oxidative stress damage to lens epithelial cell cultures is mediated by forkhead box O activity,” Investigative Ophthalmology & Visual Science, vol. 52, no. 7, pp. 4395–4401, 2011. View at Google Scholar · View at Scopus
  32. J.-L. Su, C.-Y. Yang, M. Zhao, M.-L. Kuo, and M.-L. Yen, “Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol,” The Journal of Biological Chemistry, vol. 282, no. 27, pp. 19385–19398, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Li, L. Shen, R. Chen et al., “Effects of Salivae Miltiorrhizae Liguspyragine Hydrochloride and Glucose Injection on the levels of main platelet thrombin receptors in chronic haemodialysis patients,” Chinese journal of integrative medicine, vol. 17, no. 8, pp. 625–630, 2011. View at Google Scholar · View at Scopus
  34. C. Higuchi, N. Nakamura, H. Yoshikawa, and K. Itoh, “Transient dynamic actin cytoskeletal change stimulates the osteoblastic differentiation,” Journal of Bone and Mineral Metabolism, vol. 27, no. 2, pp. 158–167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Ferlin, L. Perilli, L. Gianesello, G. Taglialavoro, and C. Foresta, “Profiling insulin like factor 3 (INSL3) signaling in human osteoblasts,” PLoS ONE, vol. 6, no. 12, Article ID e29733, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. M. K. Henry, J. T. Lynch, A. K. Eapen, and F. W. Quelle, “DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway,” Blood, vol. 98, no. 3, pp. 834–841, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Yan, J. C. Bian, L. X. Zhong, Y. Zhang, Y. Sun, and Z. P. Liu, “Oxidative stress and apoptotic changes of rat cerebral cortical neurons exposed to cadmium in vitro,” Biomedical and Environmental Sciences, vol. 25, no. 2, pp. 172–181, 2012. View at Google Scholar
  38. S. Burattini, S. Salucci, V. Baldassarri et al., “Anti-apoptotic activity of hydroxytyrosol and hydroxytyrosyl laurate,” Food and Chemical Toxicology, vol. 55, pp. 248–256, 2013. View at Publisher · View at Google Scholar
  39. S. Yamada, M. Taniguchi, M. Tokumoto et al., “The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease,” Journal of Bone and Mineral Research, vol. 27, no. 2, pp. 474–485, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. C. Shang, Z. Z. Chong, J. Hou, and K. Maiese, “Wnt1, FoxO3a, and NF-κB oversee microglial integrity and activation during oxidant stress,” Cellular Signalling, vol. 22, no. 9, pp. 1317–1329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Ganesan, B. L. Unger, A. T. Comstock et al., “Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A,” Thorax, vol. 68, no. 2, pp. 131–141, 2013. View at Publisher · View at Google Scholar
  42. J. L. Brubacher and N. C. Bols, “Chemically de-acetylated 2′,7′-dichlorodihydrofluorescein diacetate as a probe of respiratory burst activity in mononuclear phagocytes,” Journal of Immunological Methods, vol. 251, no. 1-2, pp. 81–91, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Accili and K. C. Arden, “FoxOs at the crossroads of cellular metabolism, differentiation, and transformation,” Cell, vol. 117, no. 4, pp. 421–426, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Hoogeboom, M. A. G. Essers, P. E. Polderman, E. Voets, L. M. M. Smits, and B. M. T. Burgering, “Interaction of FOXO with β-catenin inhibits β-catenin/T cell factor activity,” The Journal of Biological Chemistry, vol. 283, no. 14, pp. 9224–9230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. H. J. Kim, E.-J. Chang, H.-M. Kim et al., “Antioxidant α-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-κB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-κB ligand and tumor necrosis factor-α,” Free Radical Biology and Medicine, vol. 40, no. 9, pp. 1483–1493, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. X.-C. Bai, D. Lu, J. Bai et al., “Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κB,” Biochemical and Biophysical Research Communications, vol. 314, no. 1, pp. 197–207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. C.-M. Bäckesjö, Y. Li, U. Lindgren, and L.-A. Haldosén, “Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells,” Journal of Bone and Mineral Research, vol. 21, no. 7, pp. 993–1002, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Uysal, S. Gorgulu, A. Yagci, Y. Karslioglu, O. Gunhan, and D. Sagdic, “Effect of resveratrol on bone formation in the expanded inter-premaxillary suture: early bone changes,” Orthodontics and Craniofacial Research, vol. 14, no. 2, pp. 80–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. S. M. Durbin, J. R. Jackson, M. J. Ryan, J. C. Gigliotti, S. E. Alway, and J. C. Tou, “Resveratrol supplementation influences bone properties in the tibia of hindlimb-suspended mature Fisher 344 x Brown Norway male rats,” Applied Physiology, Nutrition, and Metabolism, vol. 37, no. 6, pp. 1179–1188, 2012. View at Publisher · View at Google Scholar
  50. O. Kutuk, M. Adli, G. Poli, and H. Basaga, “Resveratrol protects against 4-HNE induced oxidative stress and apoptosis in Swiss 3T3 fibroblasts,” BioFactors, vol. 20, no. 1, pp. 1–10, 2004. View at Google Scholar · View at Scopus
  51. Y. Zheng, Y. Liu, J. Ge et al., “Resveratrol protects human lens epithelial cells against H2O2 induced oxidative stress by increasing catalase, SOD-1, and HO-1 expression,” Molecular Vision, vol. 16, pp. 1467–1474, 2010. View at Google Scholar · View at Scopus
  52. D. H. Lee, B.-S. Lim, Y.-K. Lee, and H.-C. Yang, “Effects of hydrogen peroxide (H2O2) on alkaline phosphatase activity and matrix mineralization of odontoblast and osteoblast cell lines,” Cell Biology and Toxicology, vol. 22, no. 1, pp. 39–46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Krakstad and M. Chekenya, “Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics,” Molecular Cancer, vol. 9, article 135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Maiese, Z. Z. Chong, and F. Li, “Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors,” Current Neurovascular Research, vol. 2, no. 5, pp. 425–446, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. C. S. Yan, Z. C. Zhao, H. Jinling, and K. Maiese, “FoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis,” Current Neurovascular Research, vol. 6, no. 4, pp. 223–238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. S. P. Tenbaum, P. Ordonez-Moran, I. Puig et al., “β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer,” Nature Medicine, vol. 18, no. 6, pp. 892–901, 2012. View at Publisher · View at Google Scholar
  57. D. Chen, M. Zhao, and G. R. Mundy, “Bone morphogenetic proteins,” Growth Factors, vol. 22, no. 4, pp. 233–241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Katagiri, A. Yamaguchi, M. Komaki et al., “Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage,” Journal of Cell Biology, vol. 127, no. 6 I, pp. 1755–1766, 1994. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Rawadi, B. Vayssière, F. Dunn, R. Baron, and S. Roman-Roman, “BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop,” Journal of Bone and Mineral Research, vol. 18, no. 10, pp. 1842–1853, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Y. Shin, C. G. Kim, E.-H. Jho et al., “Hydrogen peroxide negatively modulates Wnt signaling through downregulation of β-catenin,” Cancer Letters, vol. 212, no. 2, pp. 225–231, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Funato, T. Michiue, M. Asashima, and H. Miki, “The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled,” Nature cell biology, vol. 8, no. 5, pp. 501–508, 2006. View at Google Scholar · View at Scopus
  62. T. A. Bailey, N. Kanuga, I. A. Romero, J. Greenwood, P. J. Luthert, and M. E. Cheetham, “Oxidative stress affects the junctional integrity of retinal pigment epithelial cells,” Investigative Ophthalmology and Visual Science, vol. 45, no. 2, pp. 675–684, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. Chen, Y. Hu, T. Zhou et al., “Activation of the wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models,” American Journal of Pathology, vol. 175, no. 6, pp. 2676–2685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Zhou, K. K. Zhou, K. Lee et al., “The role of lipid peroxidation products and oxidative stress in activation of the canonical wingless-type MMTV integration site (WNT) pathway in a rat model of diabetic retinopathy,” Diabetologia, vol. 54, no. 2, pp. 459–468, 2011. View at Publisher · View at Google Scholar · View at Scopus